Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Applied Tofacitinib Citrate (CP-690550 citrate) in Immune Re
2026-05-09
Tofacitinib citrate (CP-690550 citrate) offers bench researchers nanomolar JAK3 inhibition for dissecting immune regulation and inflammatory disorder pathways. This guide translates cutting-edge comparative vascular safety data and hands-on protocol refinements into actionable workflows, troubleshooting, and optimization tips for reliable immune modulation studies.
-
IGF2BP3–FZD1/7 Axis Drives Stemness and Chemoresistance in T
2026-05-09
This study identifies IGF2BP3 as a dominant m6A reader stabilizing FZD1/7 transcripts, thereby promoting cancer stem-like properties and carboplatin resistance in triple-negative breast cancer (TNBC). Targeting this axis may improve therapy efficacy by sensitizing TNBC stem cells to chemotherapy while reducing toxicity.
-
Meropenem: Applied Workflows in β-Lactam Carbapenem Research
2026-05-08
Meropenem, an ultra-broad-spectrum β-lactam antibiotic carbapenem, enables robust modeling of Gram-negative and Gram-positive bacterial resistance in both basic and translational research. This guide details stepwise experimental enhancements, protocol-critical parameters, and troubleshooting strategies that maximize Meropenem’s reliability for resistance and septicemia studies.
-
Temozolomide: Alkylating Agent for DNA Repair & Glioma Model
2026-05-07
Temozolomide is a validated small-molecule alkylating agent used to induce DNA damage in cancer model research. Its spontaneous methylation of guanine bases makes it indispensable for studying DNA repair mechanisms and chemotherapy resistance. APExBIO's Temozolomide supports reproducible workflows in glioma and oncology studies.
-
Bay 11-7821 (BAY 11-7082): Precision IKK Inhibition for Canc
2026-05-07
Bay 11-7821 (BAY 11-7082) empowers researchers with robust, selective inhibition of the NF-κB pathway, enabling reproducible dissection of inflammation and apoptosis in cancer and immunology models. Its versatility in cell-based and in vivo workflows—combined with actionable troubleshooting and optimization tips—makes it an essential tool for next-generation translational research.
-
Caspase-3 Fluorometric Assay Kit: Workflow & Applied Insight
2026-05-06
Leverage the Caspase-3 Fluorometric Assay Kit for rapid, quantitative assessment of apoptosis and caspase signaling in complex disease models. This guide delivers protocol optimizations, troubleshooting strategies, and actionable insights based on recent mechanistic breakthroughs and expert workflows.
-
Dual Luciferase Reporter Gene System: Precision in Osteogeni
2026-05-06
The Dual Luciferase Reporter Gene System empowers researchers to dissect transcriptional events and regulatory pathways with unmatched sensitivity. This article details protocol enhancements and troubleshooting tips for high-throughput luciferase detection, drawing on recent breakthroughs in stem cell osteogenesis.
-
Dual Luciferase Reporter Gene System: High-Throughput Insigh
2026-05-05
Unlock precise normalization and high-throughput transcriptional studies with the Dual Luciferase Reporter Gene System. This assay enables robust, sequential bioluminescence analysis, allowing researchers to dissect complex regulatory pathways with confidence.
-
Refining In Vitro Drug Response Evaluation in Oncology Resea
2026-05-05
Schwartz’s dissertation advances in vitro drug testing by distinguishing between proliferative arrest and cell death, introducing precise viability metrics that clarify drug response mechanisms. These methodological improvements are highly relevant for researchers developing anti-angiogenic therapies such as Tivozanib (AV-951).
-
Bay 11-7821: Precision IKK Inhibition for Inflammation Resea
2026-05-04
Bay 11-7821 (BAY 11-7082) uniquely enables targeted NF-κB pathway inhibition and apoptosis regulation in advanced inflammatory and cancer research. This guide details optimized workflows, troubleshooting strategies, and key innovations from recent sepsis studies, offering actionable protocols and comparative insights for translational labs.
-
Caspase-3 Fluorometric Assay Kit: Applied Workflows & Insigh
2026-05-04
Unlock quantitative, reproducible caspase activity measurement with APExBIO's Caspase-3 Fluorometric Assay Kit. This article delivers stepwise protocols, troubleshooting strategies, and translational guidance for apoptosis research and beyond.
-
Q-VD-OPh: Pan-Caspase Inhibitor Empowering Apoptosis Researc
2026-05-03
Q-VD-OPh, a potent and brain-permeable pan-caspase inhibitor, transforms apoptosis research by enabling precise, reproducible inhibition of caspase-driven pathways in vitro and in vivo. Its robust performance in neurodegenerative models and cell viability enhancement distinguishes it as an essential tool for translational and basic biomedical studies.
-
Practical Use of HyperPFU™ High-Fidelity DNA Polymerase in P
2026-05-02
HyperPFU™ high-fidelity DNA polymerase is engineered for accurate PCR amplification of long, GC-rich, or otherwise challenging DNA templates, where standard Taq or lower-fidelity enzymes are prone to errors or processivity issues. It is recommended for applications requiring blunt-ended, high-fidelity products, but is not suitable for workflows needing 3'-A overhangs or sticky ends.
-
Q-VD-OPh: Pan-Caspase Inhibitor Workflows for Apoptosis Rese
2026-05-02
Q-VD-OPh delivers robust, cell-permeable pan-caspase inhibition for dissecting apoptosis and preserving cell viability in demanding experimental contexts. Its in vitro and in vivo versatility makes it a cornerstone for neurodegeneration, cancer, and cell stress models, enabling reproducible, high-sensitivity protocols.
-
Technical Use of HyperPFU™ High-Fidelity DNA Polymerase in P
2026-05-01
HyperPFU™ high-fidelity DNA polymerase is engineered for robust, accurate PCR amplification of long, GC-rich, or otherwise difficult DNA templates. It is best suited for workflows that require blunt-ended, high-fidelity products, but it is not appropriate for applications that rely on 3'-A overhangs or sticky-end generation.
8767 records 13/585 page Previous Next First page 上5页 1112131415 下5页 Last page